26.11.2012 Views

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

Guidelines for ATC classification and DDD assignment - WHOCC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A. Drug utilization<br />

The <strong>ATC</strong>/<strong>DDD</strong> system can be used <strong>for</strong> collection of drug utilization statistics in a<br />

variety of settings <strong>and</strong> from a variety of sources.<br />

Examples are:<br />

- Sales data such as wholesale data at a national, regional or local level.<br />

- Dispensing data either comprehensive or sampled. Computerised pharmacies can<br />

easily collect data on drugs dispensed. Alternatively, sample data can be<br />

collected manually. Reimbursement systems, which operate in a number of<br />

countries at the national level provide comprehensive dispensing data down to<br />

the individual prescription level, as all prescriptions are submitted <strong>and</strong> recorded<br />

<strong>for</strong> reimbursement. This is generally called “claims” data. Similar data are often<br />

available through health insurance or health maintenance organisations.<br />

These databases can sometimes allow collection of demographic in<strong>for</strong>mation on<br />

the patients, <strong>and</strong> in<strong>for</strong>mation on dose, duration of treatment <strong>and</strong> co-prescribing.<br />

Less commonly, linkage to hospital <strong>and</strong> medical databases can provide<br />

in<strong>for</strong>mation on indications, <strong>and</strong> outcomes such as hospitalisation, use of specific<br />

medical services, <strong>and</strong> adverse drug reactions.<br />

- Patient encounter based data. This is usually collected by specially designed<br />

sampling studies such as those carried out by market research organisations.<br />

However, increasing use of in<strong>for</strong>mation technology at the medical practice level<br />

will make such data available more widely in the near future. These methods<br />

have the advantage of potentially providing accurate in<strong>for</strong>mation on Prescribed<br />

Daily Doses, patient demographics, duration of therapy, co-prescribing,<br />

indications, morbidity <strong>and</strong> co-morbidity, <strong>and</strong> sometimes outcomes.<br />

- Patient survey data. Collection of data at the patient level can provide<br />

in<strong>for</strong>mation about actual drug consumption <strong>and</strong> takes into account compliance in<br />

filling prescriptions <strong>and</strong> taking medications as prescribed. It can also provide<br />

qualitative in<strong>for</strong>mation about perceptions, beliefs, <strong>and</strong> attitudes to the use of<br />

medicines.<br />

- Health Facility data. Data on medication use at all the above levels is often<br />

available in health care settings such as hospitals <strong>and</strong> health centres at regional,<br />

district, or village level.<br />

33

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!